CRISPR-UMI: single-cell lineage tracing of pooled CRISPR-Cas9 screens.
Georg MichlitsMaria HubmannSzu-Hsien WuGintautas VainoriusElena BudusanSergei ZhukThomas R BurkardMaria NovatchkovaMartin AichingerYiqing LuJohn Reece-HoyesRoberto NitschDaniel SchramekDominic HoepfnerUlrich EllingPublished in: Nature methods (2017)
Pooled CRISPR screens are a powerful tool for assessments of gene function. However, conventional analysis is based exclusively on the relative abundance of integrated single guide RNAs (sgRNAs) between populations, which does not discern distinct phenotypes and editing outcomes generated by identical sgRNAs. Here we present CRISPR-UMI, a single-cell lineage-tracing methodology for pooled screening to account for cell heterogeneity. We generated complex sgRNA libraries with unique molecular identifiers (UMIs) that allowed for screening of clonally expanded, individually tagged cells. A proof-of-principle CRISPR-UMI negative-selection screen provided increased sensitivity and robustness compared with conventional analysis by accounting for underlying cellular and editing-outcome heterogeneity and detection of outlier clones. Furthermore, a CRISPR-UMI positive-selection screen uncovered new roadblocks in reprogramming mouse embryonic fibroblasts as pluripotent stem cells, distinguishing reprogramming frequency and speed (i.e., effect size and probability). CRISPR-UMI boosts the predictive power, sensitivity, and information content of pooled CRISPR screens.
Keyphrases
- crispr cas
- genome editing
- single cell
- genome wide
- high throughput
- rna seq
- dna methylation
- copy number
- randomized controlled trial
- healthcare
- clinical trial
- wastewater treatment
- adipose tissue
- gene expression
- type diabetes
- oxidative stress
- phase iii
- metabolic syndrome
- antibiotic resistance genes
- open label
- microbial community
- mesenchymal stem cells
- anaerobic digestion